These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7958272)

  • 1. Transient elevation of cAMP by prostaglandins triggers subsequent up-regulation of LDL receptor activity in cultured human cells.
    Nield H; Middleton B
    Biochem Soc Trans; 1994 May; 22(2):210S. PubMed ID: 7958272
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandins which elevate cyclic AMP increase low density lipoprotein receptor mRNA and activity in human extra-hepatic cells.
    Nield H; Middleton B
    Biochem Soc Trans; 1995 Feb; 23(1):5S. PubMed ID: 7758763
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysosome inhibitors enhance the ability of cyclic AMP-elevating agents to induce the LDL receptor in human vascular smooth muscle cells.
    Middleton B
    Biochem Biophys Res Commun; 1992 Jan; 182(2):830-5. PubMed ID: 1310398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of low density lipoprotein receptor gene expression in cultured human granulosa cells: roles of human chorionic gonadotropin, 8-bromo-3',5'-cyclic adenosine monophosphate, and protein synthesis.
    Golos TG; Strauss JF
    Mol Endocrinol; 1987 Apr; 1(4):321-6. PubMed ID: 2840565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP-mediated hormonal control of LDL receptor activity in cultured human cells.
    Nield H; Hartley R; Middleton B
    Biochem Soc Trans; 1993 May; 21(2):130S. PubMed ID: 7689492
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic AMP stimulates the synthesis and function of the low-density lipoprotein receptor in human vascular smooth-muscle cells and fibroblasts.
    Middleton B; Middleton A
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):853-61. PubMed ID: 1313231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of the thyroid gland--the roles of cAMP and prostaglandins--and Graves' disease].
    Takasu N
    Horumon To Rinsho; 1983 Apr; 31(4):325-49. PubMed ID: 6309437
    [No Abstract]   [Full Text] [Related]  

  • 8. Histamine increases the expression of LOX-1 via H2 receptor in human monocytic THP-1 cells.
    Tanimoto A; Murata Y; Nomaguchi M; Kimura S; Arima N; Xu H; Hamada T; Sasaguri Y
    FEBS Lett; 2001 Nov; 508(3):345-9. PubMed ID: 11728449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of cyclic AMP concentrations in cultured vascular smooth muscle cells by vasoactive peptide hormones. Role of endogenous prostaglandins.
    Hassid A
    J Pharmacol Exp Ther; 1986 Nov; 239(2):334-9. PubMed ID: 3021953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins and intracellular cyclic AMP in respiratory secretory cells.
    Lazarus SC; Basbaum CB; Gold WM
    Am Rev Respir Dis; 1984 Aug; 130(2):262-6. PubMed ID: 6087701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valinomycin pretreatment induced LDL receptor activity in cultured human cells.
    Nield H; Middleton B
    Biochem Soc Trans; 1993 May; 21(2):131S. PubMed ID: 8359386
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of cyclic 3'5'-adenosine monophosphate in cultured renal (MDCK) cells by endogenous prostaglandins.
    Hassid A
    J Cell Physiol; 1983 Sep; 116(3):297-302. PubMed ID: 6309869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostaglandins and the organ of vision. III. Effect of prostaglandins on the adenyl cyclase system and the cyclic adenosine monophosphate (cycl AMP)].
    Tuszewska R
    Klin Oczna; 1976; 46(4):459-64. PubMed ID: 177802
    [No Abstract]   [Full Text] [Related]  

  • 14. The upstream promoter of the human LDL receptor gene does not contain a cyclic AMP response element.
    Takagi K; Hoffman EK; Strauss JF
    Biochem Biophys Res Commun; 1988 Apr; 152(1):143-8. PubMed ID: 2833885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclic adenosine monophosphate and prostaglandins in oncology].
    Bershteĭn LM; Dil'man VM
    Vopr Onkol; 1974; 20(3):105-20. PubMed ID: 4373912
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of vasodilatory prostaglandins with respect to cAMP-mediated phosphorylation of a target substrate in intact human platelets.
    Nolte C; Eigenthaler M; Schanzenbächer P; Walter U
    Biochem Pharmacol; 1991 Jul; 42(2):253-62. PubMed ID: 1713458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interrelations among prostaglandins, cyclic AMP and calcium ions in regulation of the inflammatory process].
    Chiarini P
    Recenti Prog Med; 1980 Sep; 69(3):265-77. PubMed ID: 6256834
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostaglandins and cyclic AMP.
    Butcher RW
    Adv Biochem Psychopharmacol; 1970; 3():173-83. PubMed ID: 4331455
    [No Abstract]   [Full Text] [Related]  

  • 19. Concerted transcriptional activation of the low density lipoprotein receptor gene by insulin and luteinizing hormone in cultured porcine granulosa-luteal cells: possible convergence of protein kinase a, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase signaling pathways.
    Sekar N; Veldhuis JD
    Endocrinology; 2001 Jul; 142(7):2921-8. PubMed ID: 11416012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide and forskolin stimulate interleukin 6 production by rat cortical astrocytes in culture via a cyclic AMP-dependent, prostaglandin-independent mechanism.
    Grimaldi M; Pozzoli G; Navarra P; Preziosi P; Schettini G
    J Neurochem; 1994 Jul; 63(1):344-50. PubMed ID: 8207438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.